Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SM2O
|
|||
| Drug Name |
N-(pyridinepyrroylylcarbonyl)-piperidine derivative 1
|
|||
| Synonyms |
PMID28895472-Compound-16
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ASTELLAS PHARMA INC. AZAMI, Hidenori ABE, Tomoaki KAKEFUDA, Akio HIRANO, Masaaki WATANABE, Kazushi
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H23N3O2
|
|||
| Canonical SMILES |
CC(C)(CC1CCN(CC1)C(=O)C2=CC3=C(N2)C=NC=C3)O
|
|||
| InChI |
1S/C17H23N3O2/c1-17(2,22)10-12-4-7-20(8-5-12)16(21)14-9-13-3-6-18-11-15(13)19-14/h3,6,9,11-12,19,22H,4-5,7-8,10H2,1-2H3
|
|||
| InChIKey |
HSSJHQZLKSLBPS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dihydrodiol dehydrogenase type I (AKR1C3) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Dihydrodiol dehydrogenase type I (AKR1C3) | Target's Patent Info | [1] | |
| BioCyc | Superpathway of steroid hormone biosynthesis | |||
| Allopregnanolone biosynthesis | ||||
| Androgen biosynthesis | ||||
| KEGG Pathway | Steroid hormone biosynthesis | |||
| Arachidonic acid metabolism | ||||
| Metabolic pathways | ||||
| Ovarian steroidogenesis | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| Reactome | Retinoid metabolism and transport | |||
| WikiPathways | Metapathway biotransformation | |||
| Benzo(a)pyrene metabolism | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review.Expert Opin Ther Pat. 2017 Dec;27(12):1329-1340. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.